A Review on Potential Mechanisms of Terminalia chebula in Alzheimer's Disease

AR Afshari, HR Sadeghnia… - … in Pharmacological and …, 2016 - Wiley Online Library
The current management of Alzheimer's disease (AD) focuses on acetylcholinesterase
inhibitors (AChEIs) and NMDA receptor antagonists, although outcomes are not completely …

[PDF][PDF] Pomegranate seed oil: A comprehensive review on its therapeutic effects

MT Boroushaki, H Mollazadeh, AR Afshari - Int J Pharm Sci Res, 2016 - researchgate.net
Pomegranate, Punica granatum L.(Punicaceae), as a medicinal and nutritional ancient fruit,
has an outstanding medical history throughout the world. Each of compartments of …

[HTML][HTML] The prevalence and severity of potential drug-drug interactions among adult polypharmacy patients at outpatient clinics in Jordan

MB Nusair, SI Al-Azzam, RM Arabyat, HA Amawi… - Saudi Pharmaceutical …, 2020 - Elsevier
Objective To assess the prevalence of potential drug-drug interactions (pDDIs) among
polypharmacy patients in Jordan using Lexicomp®. Additionally, this study aims to …

[HTML][HTML] Review on the potential therapeutic roles of nigella sativa in the treatment of patients with cancer: Involvement of apoptosis:-black cumin and cancer

H Mollazadeh, AR Afshari… - Journal of …, 2017 - ncbi.nlm.nih.gov
Nigella sativa (N. sativa, family Ranunculaceae) is a medicinal plant that has been widely
used for centuries throughout the world as a natural remedy. A wide range of chemical …

A study of harmful drug–drug interactions due to polypharmacy in hospitalized patients in Goa Medical College

A Khandeparkar, PV Rataboli - Perspectives in clinical research, 2017 - journals.lww.com
Materials and Methods: A prospective, cross-sectional, observational study was performed
from July 2011 to June 2012. Approval was obtained from the Institutional Ethics Committee …

Risk of drug-drug interactions in out-hospital drug dispensings in France: results from the DRUG-drug interaction prevalence study

L Létinier, S Cossin, Y Mansiaux, M Arnaud… - Frontiers in …, 2019 - frontiersin.org
Introduction: Drug interactions could account for 1% of hospitalizations in the general
population and 2–5% of hospital admissions in the elderly. However, few data are available …

[HTML][HTML] Potential drug-drug interactions among hospitalized patients in a develo** country

S Mousavi, G Ghanbari - Caspian journal of internal medicine, 2017 - ncbi.nlm.nih.gov
Background: Drug-drug interactions (DDIs) may often lead to preventable adverse drug
events and health damage. Particularly in hospitals, this might be an important factor as …

The practice of the community pharmacists in managing potential drug-drug interactions: a simulated patient visits

RM Hamadouk, ED Albashair… - Integrated Pharmacy …, 2022 - Taylor & Francis
Background Drug-drug interactions (DDIs) can cause treatment failure and serious adverse
drug reactions, leading to morbidity and mortality. Due to their significant effects on the …

Determination of potential drug–drug interactions in prescription orders dispensed in a community pharmacy setting using Micromedex® and Lexicomp®: a …

A Abbas, S Al-Shaibi, S Sankaralingam… - International Journal of …, 2022 - Springer
Background Community pharmacists have a role in identifying drug–drug interactions (DDIs)
when processing prescription orders and dispensing medications to patients. The harmful …

A comprehensive review on the potential therapeutic benefits of phosphodiesterase inhibitors on cardiovascular diseases

R Shafiee-Nick, AR Afshari, SH Mousavi… - Biomedicine & …, 2017 - Elsevier
Phosphodiesterases are a group of enzymes that hydrolyze cyclic nucleotides, which
assume a key role in directing intracellular levels of the second messengers' cAMP and …